GS
GlobeStar Therapeutics Corporation
GSTC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $124.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive EV/EBITDA 72.89x
P/E N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
100 /100
Excellent ROIC 174.56%
ROE N/A
ROA N/A
Debt
0 /100
High Current ratio 0.00x
Int. coverage -20.28x
Net debt/EBITDA 54.43x
Stability
27 /100
Unstable Beta 1.11x
EPS volatility 620.41%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na GSTC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James C. Katzaroff
Employees
0
Headquarters
New York